Institutional investors purchased a net $3.1 million shares of NVO during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 9.91% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BBVA BANCOMER GESTIÓN SA DE CV Bought 32.8 Thousand shares of Novo Nordisk
IMPULSORA DE FONDOS BANAMEX SA D... Bought 6.4 Thousand shares of Novo Nordisk
BANKHAUS VON DER HEYDT GMBH & CO... Bought 25.00 shares of Novo Nordisk